VP4-2021: EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9: Interim analysis of phase III trial of cemiplimab vs. investigator's choice (IC) chemotherapy (chemo) in recurrent/metastatic (R/M) cervical carcinoma

Krishnansu S. Tewari, Bradley J. Monk, Ignace Vergote, Austin Miller, Andréia Cristina de Melo, H.S. Kim, Y.M. Kim, Alla Lisyanskaya, Vanessa Samouëlian, Domenica Lorusso, Fernanda Damian, Chang Cl, E.A. Gotovkin, Shunji Takahashi, Daniella Ramone, Joanna Pikiel, J. Li, Melissa Mathias, Matthew G. Fury, Ana Oaknin